Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
HEALTHEQUITY, INC.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-49.9% vs price
Base Case (Median)
-21.1% vs price
Bull Case (75th pct.)
54.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $169.61 | 88.5% | High (40%) |
| PE Comparable | $71.04 | -21.1% | Medium (25%) |
| Growth Trajectory DCF | $316.45 | 251.6% | Medium (20%) |
| Graham Number | $39.69 | -55.9% | Low (10%) |
| EV/EBITDA | $50.49 | -43.9% | Medium (20%) |
| EV/FCF | $108.81 | 20.9% | Medium (20%) |
| Earnings Power Value | $26.87 | -70.1% | Medium (50%) |
Based on 7 out of 7 methods, HQY appears fairly valued at the current price of $90.00. The base case fair value of $71.04 implies 21.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.